Last reviewed · How we verify

NCT04252326: KAPHWDHRC

The Knowledge, Attitudes and Practices of Healthcare Workers on Drug Hypersensitivity Reactions in Children

Completed NA Last updated 21 September 2020
What this trial tests

NA trial testing Survey in Adverse Drug Reactions in 354 participants. Completed in 1 March 2020.

Timeline
1 January 2020
Primary endpoint
1 February 2020
1 March 2020

Quick facts

Lead sponsorSaglik Bilimleri Universitesi
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designfactorial
Maskingnone
Primary purposehealth services research
Enrollment354
Start date1 January 2020
Primary completion1 February 2020
Estimated completion1 March 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Saglik Bilimleri Universitesi — full company profile →

Who can join

Eligibility, any sex, with Adverse Drug Reactions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Adverse drug reactions are an important public health consern that affects physician prescriptions and practice. The responsibilities of healthcare professionals in monitoring, prevention, treatment and reporting of drug hypersensitivity reactions and drug allergies are essential for patient safety. Providing drug safety must be one of the main goals to be achieved for every member of our society. In our study, we planned to evaluate the knowledge, attitudes, and behaviors of healthcare workers in our country about drug hypersensitivity reactions in pediatric patients and to determine the risk factors that may affect them.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Survey

Trials testing the same drug.

Other recruiting trials for Adverse Drug Reactions

Currently open trials in the same condition.

Other Saglik Bilimleri Universitesi trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04252326.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing